Cargando…

The variants question: What is the problem?

The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) originated in Wuhan, China in early December 2019 has rapidly widespread worldwide. Over the course of the pandemic, due to the advance of whole‐genome sequencing technologies, an unprecedented number of genomes have been generated, pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zella, Davide, Giovanetti, Marta, Benedetti, Francesca, Unali, Francesco, Spoto, Silvia, Guarino, Michele, Angeletti, Silvia, Ciccozzi, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426965/
https://www.ncbi.nlm.nih.gov/pubmed/34255352
http://dx.doi.org/10.1002/jmv.27196
_version_ 1783750116614602752
author Zella, Davide
Giovanetti, Marta
Benedetti, Francesca
Unali, Francesco
Spoto, Silvia
Guarino, Michele
Angeletti, Silvia
Ciccozzi, Massimo
author_facet Zella, Davide
Giovanetti, Marta
Benedetti, Francesca
Unali, Francesco
Spoto, Silvia
Guarino, Michele
Angeletti, Silvia
Ciccozzi, Massimo
author_sort Zella, Davide
collection PubMed
description The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) originated in Wuhan, China in early December 2019 has rapidly widespread worldwide. Over the course of the pandemic, due to the advance of whole‐genome sequencing technologies, an unprecedented number of genomes have been generated, providing both invaluable insights into the ongoing evolution and epidemiology of the virus and allowing the identification of hundreds of circulating genetic variants during the pandemic. In recent months variants of SARS‐CoV‐2 that have an increased number of mutations on the Spike protein have brought concern all over the world. These have been called “variants of concerns” (VOCs), and/or “variants of interests” (VOIs) as it has been suggested that their genome mutations might impact transmission, immune control, and virulence. Tracking the spread of emerging SARS‐CoV‐2 variants is crucial to inform public health efforts and control the ongoing pandemic. In this review, a concise characterization of the SARS‐CoV‐2 mutational patterns of the main VOCs and VOIs circulating and cocirculating worldwide has been presented to determine the magnitude of the SARS‐CoV‐2 threat to better understand the virus genetic diversity and its potential impact on vaccination strategy.
format Online
Article
Text
id pubmed-8426965
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84269652021-09-09 The variants question: What is the problem? Zella, Davide Giovanetti, Marta Benedetti, Francesca Unali, Francesco Spoto, Silvia Guarino, Michele Angeletti, Silvia Ciccozzi, Massimo J Med Virol Reviews The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) originated in Wuhan, China in early December 2019 has rapidly widespread worldwide. Over the course of the pandemic, due to the advance of whole‐genome sequencing technologies, an unprecedented number of genomes have been generated, providing both invaluable insights into the ongoing evolution and epidemiology of the virus and allowing the identification of hundreds of circulating genetic variants during the pandemic. In recent months variants of SARS‐CoV‐2 that have an increased number of mutations on the Spike protein have brought concern all over the world. These have been called “variants of concerns” (VOCs), and/or “variants of interests” (VOIs) as it has been suggested that their genome mutations might impact transmission, immune control, and virulence. Tracking the spread of emerging SARS‐CoV‐2 variants is crucial to inform public health efforts and control the ongoing pandemic. In this review, a concise characterization of the SARS‐CoV‐2 mutational patterns of the main VOCs and VOIs circulating and cocirculating worldwide has been presented to determine the magnitude of the SARS‐CoV‐2 threat to better understand the virus genetic diversity and its potential impact on vaccination strategy. John Wiley and Sons Inc. 2021-07-28 2021-12 /pmc/articles/PMC8426965/ /pubmed/34255352 http://dx.doi.org/10.1002/jmv.27196 Text en © 2021 The Authors. Journal of Medical Virology Published by Wiley Periodicals LLC https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Zella, Davide
Giovanetti, Marta
Benedetti, Francesca
Unali, Francesco
Spoto, Silvia
Guarino, Michele
Angeletti, Silvia
Ciccozzi, Massimo
The variants question: What is the problem?
title The variants question: What is the problem?
title_full The variants question: What is the problem?
title_fullStr The variants question: What is the problem?
title_full_unstemmed The variants question: What is the problem?
title_short The variants question: What is the problem?
title_sort variants question: what is the problem?
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426965/
https://www.ncbi.nlm.nih.gov/pubmed/34255352
http://dx.doi.org/10.1002/jmv.27196
work_keys_str_mv AT zelladavide thevariantsquestionwhatistheproblem
AT giovanettimarta thevariantsquestionwhatistheproblem
AT benedettifrancesca thevariantsquestionwhatistheproblem
AT unalifrancesco thevariantsquestionwhatistheproblem
AT spotosilvia thevariantsquestionwhatistheproblem
AT guarinomichele thevariantsquestionwhatistheproblem
AT angelettisilvia thevariantsquestionwhatistheproblem
AT ciccozzimassimo thevariantsquestionwhatistheproblem
AT zelladavide variantsquestionwhatistheproblem
AT giovanettimarta variantsquestionwhatistheproblem
AT benedettifrancesca variantsquestionwhatistheproblem
AT unalifrancesco variantsquestionwhatistheproblem
AT spotosilvia variantsquestionwhatistheproblem
AT guarinomichele variantsquestionwhatistheproblem
AT angelettisilvia variantsquestionwhatistheproblem
AT ciccozzimassimo variantsquestionwhatistheproblem